
News|Articles|January 1, 2006
Pipeline Preview
Methylphenidate transdermal patch (Daytrana, Shire/Noven) to treat attention-deficit/hyperactivity disorder (ADHD)
Advertisement
Recommendations for approval
Approvable designations
Fast-track designation
Priority review
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Medicare Part D redesign reshapes market
2
The sleep doctor who lives with a disorder he treats
3
A conversation with Tiffany Phung, Pharm.D., CSP, about how patient outcomes drive specialty pharmacy strategy
4
Rural health is ailing. Is $50 billion enough to heal it?
5













